NCT00964340 A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days Status COMPLETED Phase PHASE1
NCT00964249 Phase I Study of GW642444M in Healthy Japanese Male Subjects Status COMPLETED Phase PHASE1
NCT00964223 A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne Status COMPLETED Phase PHASE4
NCT00964158 Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A) Status COMPLETED Phase PHASE3
NCT00964106 Validation Study of Multiple Probe Compounds for Drug Interaction Evaluation Status COMPLETED Phase PHASE1
NCT00964028 Safety Study of GSK Biologicals' DTPa-IPV/Hib (Infanrix™-IPV/Hib) Status COMPLETED Phase PHASE3
NCT00963937 Study to Evaluate the Efficacy and Safety of Oral Sumatriptan for the Acute Treatment of Migraine in Children and Adolescents Status COMPLETED Phase PHASE3
NCT00959842 Effects of Lovaza on Lipoprotein Composition and Function in Mild Hypertriglyceridemia Status COMPLETED Phase PHASE1/PHASE2
NCT00958633 Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder. Status TERMINATED Phase PHASE3
NCT00955773 A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects Status COMPLETED Phase PHASE1
NCT00955682 Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK134612 Status COMPLETED Phase PHASE3
NCT00955383 GSK2190915 Safety and Pharmacokinetic Study in Healthy Japanese Subjects Status COMPLETED Phase PHASE1
NCT00953576 Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00952692 Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00951041 Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults Status COMPLETED Phase PHASE2
NCT00951015 A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects Status COMPLETED Phase PHASE2
NCT00950859 A Pilot Study Assessing the Integrase Inhibitor GSK1349572 in HIV-infected Persons With Virus Resistant to Raltegravir Status COMPLETED Phase PHASE2
NCT00950833 Long-term Follow-up Study of Children Previously Primed With GSK Pneumococcal Vaccine (GSK1024850A) and of Unprimed Children Status COMPLETED Phase PHASE3
NCT00950807 GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease Status COMPLETED Phase PHASE2